Luteotropic effects of tamoxifen in infertile women

Fertil Steril. 1984 Aug;42(2):223-7. doi: 10.1016/s0015-0282(16)48017-9.

Abstract

Tamoxifen at a dose of 10 mg/day for 5 days was given to five infertile women in the luteal phase. Daily serum samples were obtained during the luteal phase for radioimmunoassay of progesterone (P), estradiol (E2), follicle-stimulating hormone, luteinizing hormone (LH), and prolactin levels. The integrated luteal phase concentrations of serum P and E2 before and after cycles of tamoxifen treatment increased from 87.8 +/- 16.2 ng/ml and 1120 +/- 164.4 pg/ml to 131.6 +/- 18.9 ng/ml and 1461 +/- 205.2 pg/ml, respectively (P less than 0.01 and P less than 0.05). No apparent increase in circulating LH levels was seen in one of the five cases, but this patient's serum P and E2 levels rose nonetheless. This suggests that the significant increase in circulating P and E2 induced by tamoxifen is not consistently associated with an increase in serum LH concentration.

MeSH terms

  • Adult
  • Corpus Luteum / drug effects
  • Corpus Luteum / metabolism*
  • Estradiol / blood
  • Female
  • Follicle Stimulating Hormone / blood
  • Humans
  • Infertility, Female / drug therapy*
  • Luteal Phase
  • Luteinizing Hormone / blood
  • Progesterone / blood
  • Tamoxifen / therapeutic use*
  • Time Factors

Substances

  • Tamoxifen
  • Progesterone
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone